Extracorporeal treatment for tricyclic antidepressant poisoning: recommendations from the EXTRIP Workgroup.

abstract：:There has been a dramatic, worldwide expansion in life expectancy across the last century. This has resulted in a progressively more elderly and comorbid population. It is increasingly recognized that healthcare in this group needs to move to the concept of "adding life to years". Recognition and assessment of frailty...

journal_title：Seminars in dialysis

authors： Corbett RW,Brown EA

更新日期：2018-11-01 00:00:00

abstract：:Over 60% of patients initiating chronic hemodialysis in the United States have a chronic central venous catheter (CVC) as their first blood access device. Although it would be better if these patients started dialysis with fistulas, the CVC is used because it is a reliable and relatively safe method for obtaining bloo...

journal_title：Seminars in dialysis

authors： Ash SR

更新日期：2007-05-01 00:00:00

abstract：INTRODUCTION:Arteriovenous fistulas (AVF) are the preferred choice for vascular access in hemodialysis. We aim to identify factors that may contribute to AVF failure. METHODS:Data regarding AVF survival were collected from 441 patients. All AVFs were either radial or brachial, of the end-to-side variety. Parameters st...

journal_title：Seminars in dialysis

authors： Jothi S,Kg H,Lesley N,Vijayan M,Haridas Anupama S,Mathew M,Parthasarathy R,Sundarajan S,P N,Kumaraswamy L,Abraham G

更新日期：2020-09-01 00:00:00

abstract：:The increased frequency of cardiovascular disease observed in hemodialysis patients is secondary to the combination of many traditional (age, male sex, hypertension, smoking, diabetes mellitus, and dyslipidemia) and novel and uremia-related (inflammation, uremic toxins, adipokine imbalance, coagulation disorders, prot...

journal_title：Seminars in dialysis

authors： Bossola M,Tazza L

更新日期：2015-05-01 00:00:00

abstract：:Few prospective studies have looked at the incidence of hyperkalemia in outpatient hemodialysis access procedures. Our study prospectively evaluated 167 procedures using a preadmit venous blood gas (VBG) and found that 14.3% had moderate or severe hyperkalemia. When the individual procedures were analyzed it was found...

journal_title：Seminars in dialysis

authors： Ross J,DeatherageHand D

更新日期：2015-01-01 00:00:00

abstract：:Hypertension among patients on hemodialysis is common, difficult to diagnose and often inadequately controlled. Although specific blood pressure (BP) targets in this particular population are not yet established, meta-analyses of randomized trials showed that deliberate BP-lowering with antihypertensive drugs improves...

journal_title：Seminars in dialysis

authors： Georgianos PI,Agarwal R

更新日期：2018-11-01 00:00:00

abstract：:Renal osteodystrophy (ROD) is a bone disorder that occurs in chronic kidney disease (CKD) patients and is associated with 2- to 14-fold increased fracture risk compared to the general population. Risk of fractures is also increased in kidney transplant recipients especially within the first 5 years after transplantati...

journal_title：Seminars in dialysis

authors： Babayev R,Nickolas TL

更新日期：2015-11-01 00:00:00

abstract：:A patient with newly diagnosed end-stage renal disease (ESRD) received a femoral catheter for hemodialysis (HD). Shortly thereafter he developed fever, and blood cultures grew methicillin-resistant Staphylococcus aureus. The catheter was removed and the patient was treated with both vancomycin and rifampin; however, b...

journal_title：Seminars in dialysis

authors： Chang CS,Thajeb P,Chen HH,Wu CJ

更新日期：2005-07-01 00:00:00

abstract：:Recombinant human erythropoietin (rHuEPO, epoetin) revolutionized the treatment of anemia in patients with chronic kidney disease (CKD) when it was approved for use in the United States in 1989. Among dialysis patients, the mean hemoglobin (Hb) in patients undergoing dialysis rose from 7-8 g/dl prior to 1989 to 11-12 ...

journal_title：Seminars in dialysis

authors： Berns JS

更新日期：2005-01-01 00:00:00

abstract：:While vascular ultrasound (US) has been highlighted to detect vascular access stenosis, its accuracy in the identification of inflow stenosis (IS) (anastomosis and/or juxta-anastomotic area) compared with the gold standard (angiography) has not been evaluated. One hundred three consecutive fistulae referred for interv...

journal_title：Seminars in dialysis

authors： Salman L,Ladino M,Alex M,Dhamija R,Merrill D,Lenz O,Contreras G,Asif A

更新日期：2010-01-01 00:00:00

abstract：:With the current understanding that atherosclerosis is an inflammatory disorder, markers of the associated systemic inflammatory response have been extensively studied as predictors of cardiovascular disease. Recently the use of high-sensitivity C-reactive protein (hsCRP) has been proposed for risk assessment in indiv...

journal_title：Seminars in dialysis

authors： Rao M,Jaber BL,Balakrishnan VS

更新日期：2006-03-01 00:00:00

abstract：:Vancomycin, a glycopeptide antibiotic, has remained a popular antimicrobial agent throughout the past five decades, and is often included in empiric antibiotic regimens. With gram-positive coverage, it has found a niche in the treatment of methicillin-resistant Staphylococcus aureus. Although vancomycin has been in ex...

journal_title：Seminars in dialysis

authors： Pallotta KE,Manley HJ

更新日期：2008-01-01 00:00:00

abstract：:Universal lower dialysate [Na+] is often advocated as a means of improving the dire cardiovascular plight of our dialysis patients. However, there is evidence associating lower dialysate [Na+] and increased morbidity and mortality especially in frailer patients, probably as a result of more frequent intra-dialytic hyp...

journal_title：Seminars in dialysis

authors： Marshall MR,Dunlop JL

更新日期：2012-05-01 00:00:00

abstract：:Cardiovascular disease (CVD) is a major cause of morbidity and mortality worldwide. Although numerous modifiable risk factors in the pathogenesis of CVD and its associated mortality have been identified, dyslipidemia remains to be a key focus for therapy. In this regard, significant progress has been made in reducing ...

journal_title：Seminars in dialysis

authors： Moradi H,Streja E,Vaziri ND

更新日期：2018-07-01 00:00:00

abstract：:Dialysis patients are at high risk for fracture, with published rates in excess of a 20% probability of fracture over the next 10 years of dialysis. Unfortunately, there is no accepted methodology for quantifying this risk in advance of the first fracture; conventional bone densitometry performs unreliably in this rol...

journal_title：Seminars in dialysis

authors： Jamal SA,Hodsman AB

更新日期：2011-01-01 00:00:00

abstract：:Calciphylaxis, a disorder of dermal arteriolar calcification with a distinct predilection for patients with advanced kidney disease, remains an enigmatic condition that challenges clinicians. Observations regarding positive associations between levels of circulating parathyroid hormone (PTH) and the risk of calciphyla...

journal_title：Seminars in dialysis

authors： Nigwekar SU,Sprague SM

更新日期：2016-07-01 00:00:00

abstract：:In addition to extracorporeal renal replacement strategies, which in chronic kidney disease (CKD) are largely reserved for the treatment of end-stage kidney failure, conservative measures can be taken to reduce concentration, effects, or both concentration and effects of uremic retention solutes. In this overview, we ...

journal_title：Seminars in dialysis

authors： Vanholder R,Argilés A,Beige J,Brunet P,Drüeke TB,Fliser D,Herget-Rosenthal S,Hörl WH,Jörres A,Perna A,Rodriguez-Portillo M,Spasovski G,Stegmayr B,Stenvinkel P,Wanner C,Wiecek A,Massy ZA

更新日期：2009-07-01 00:00:00

abstract：:Measurements of the concentration of parathyroid hormone (PTH) in serum or plasma are used widely for the initial diagnostic assessment of patients with renal bone disease, to monitor disease progression, and to gauge responses to treatment. Several analytical methods are used to measure plasma PTH levels, and a varie...

journal_title：Seminars in dialysis

authors： Goodman WG

更新日期：2007-01-01 00:00:00

abstract：:While patients with sickle cell disease currently constitute a very small minority of the US dialysis population (0.1%), there is anticipated growth of this group as the life expectancy of those with sickle cell disease (SCD) increases. SCD patients suffer a high burden of morbidity, which is enhanced by the presence ...

journal_title：Seminars in dialysis

authors： Boyle SM,Jacobs B,Sayani FA,Hoffman B

更新日期：2016-01-01 00:00:00

abstract：:Most recent randomized controlled trials (RCTs) have found that hemodialysis graft surveillance combined with preemptive correction of stenosis does not prolong graft survival. Nevertheless, such programs may be justified if they reduce other adverse outcomes or decrease the cost of care. This study tested this hypoth...

journal_title：Seminars in dialysis

authors： Dossabhoy NR,Ram SJ,Nassar R,Work J,Eason JM,Paulson WD

更新日期：2005-11-01 00:00:00

abstract：:In healthy individuals, vitamin D produced in the skin or derived from nutritional sources is converted to 25-hydroxyvitamin D (25[OH]D) in the liver, and then 1,25-dihydroxyvitamin D (1,25[OH](2)D) by 1 alpha-hydroxylase in the kidney. Chronic kidney disease (CKD) is accompanied by a progressive decline in the abilit...

journal_title：Seminars in dialysis

authors： Bhan I,Hewison M,Thadhani R

更新日期：2010-07-01 00:00:00

abstract：:Until the discovery of calcimimetics, the management of secondary hyperparathyroidism (SHPT) relied exclusively on treatment with phosphate binders, vitamin D derivatives or surgical parathyroidectomy with limited success. The therapeutic use of calcimimetic agents, together with a better understanding of the pivotal ...

journal_title：Seminars in dialysis

authors： Rodríguez M,Goodman WG,Liakopoulos V,Messa P,Wiecek A,Cunningham J

更新日期：2015-09-01 00:00:00

abstract：:Despite improvements in the delivery of care, the annual all-cause mortality rate for end-stage renal disease (ESRD) patients is still around 220 deaths per 1000 at risk patient-years. Infection-related causes are second only to cardiovascular events as a cause for mortality among ESRD patients. Almost two-thirds of a...

journal_title：Seminars in dialysis

authors： Camins BC

更新日期：2013-07-01 00:00:00

abstract：:Recent studies have shown that patients with high peritoneal transport characteristics have substantially increased morbidity and mortality. This finding is counter-intuitive, since HTs will a priori achieve higher clearances. There are many possible causes: increased protein losses with consequent hypoalbuminemia; po...

journal_title：Seminars in dialysis

authors： Heaf J

更新日期：2000-05-01 00:00:00

abstract：:Baclofen is an oral derivative of gamma-aminobutyric acid (GABA) used to treat muscular spasticity from disorders of the central nervous system. However, it is also being used for a variety of other conditions such as musculoskeletal pain, myoclonus, and alcohol withdrawal. The elimination of baclofen is heavily depen...

journal_title：Seminars in dialysis

authors： Roberts JK,Westphal S,Sparks MA

更新日期：2015-09-01 00:00:00

abstract：:Hypermagnesemia is an uncommon electrolyte abnormality, due to the fact that magnesium toxicity is only seen in the setting of a massive exposure to exogenous magnesium, often in the setting of renal insufficiency. Here, we report a case of severe hypermagnesemia that resulted in complete paralysis that was secondary ...

journal_title：Seminars in dialysis

authors： Bansal AD,Negoianu D,Warburton KM

更新日期：2016-05-01 00:00:00

abstract：:Growing evidence has been gathered over the last 15 years regarding the role of nontraditional or uremia-related risk factors in the pathogenesis of atherosclerosis in subjects with renal failure. Among those factors, dyslipidemia, inflammation, hyperhomocysteinemia, and oxidant stress have been extensively studied. H...

journal_title：Seminars in dialysis

authors： Madore F

更新日期：2003-03-01 00:00:00

abstract：:There has been substantial growth in the variety of available antidiabetic agents during the last decade and a half. The role of these newer agents in patients with diabetes and end-stage renal disease (ESRD) population, and their relative benefits and risks in this population compared to patients without ESRD are not...

journal_title：Seminars in dialysis

authors： Boyle SM,Simon B,Kobrin SM

更新日期：2015-07-01 00:00:00

abstract：:Patients on chronic hemodialysis have a shortened survival compared to the general population. There are multiple sources of morbidity and mortality unique to the dialysis population that account for this. Reasons include the effects of blood membrane interactions, intradialytic hypotension, myocardial stunning, exces...

journal_title：Seminars in dialysis

authors： Stegmayr BG

更新日期：2016-11-01 00:00:00

abstract：:Parathyroidectomy (PTX) remains an important intervention for dialysis patients with poorly controlled secondary hyperparathyroidism (SHPT), though there are only retrospective and observational data that show a mortality benefit to this procedure. Potential consequences that we seek to avoid after PTX include persist...

journal_title：Seminars in dialysis

authors： Kakani E,Sloan D,Sawaya BP,El-Husseini A,Malluche HH,Rao M

更新日期：2019-11-01 00:00:00